tiprankstipranks
Trending News
More News >
Ascom Holding AG (CH:ASCN)
:ASCN

Ascom Holding AG (ASCN) AI Stock Analysis

Compare
2 Followers

Top Page

CH:ASCN

Ascom Holding AG

(ASCN)

Select Model
Select Model
Select Model
Outperform 78 (OpenAI - 5.2)
Rating:78Outperform
Price Target:
CHF6.00
▲(18.81% Upside)
Action:UpgradedDate:03/12/26
The score is driven primarily by improving financial performance and a low-risk balance sheet (no reported debt), supported by a positive technical trend and an undemanding valuation (P/E 8.953). The main offset is modest/uneven revenue growth and historical cash-flow volatility.
Positive Factors
Conservative Balance Sheet
No reported debt across 2023–2025 materially reduces financial risk and interest expense, giving management durable flexibility to fund capex, R&D, or tuck-in M&A from internal resources. Low leverage supports resilience in downturns and preserves strategic optionality over 2–6 months.
Mission-critical Healthcare Model
Ascom’s focus on mission-critical hospital communications creates high switching costs, strong uptime requirements and an installed base that generates recurring services, maintenance and upgrade revenue. This structural demand and integration with hospital IT supports steady aftermarket cash flows over time.
Improved Profitability and Cash Generation
A 2025 rebound in net income and materially stronger free cash flow (FCF close to net income) indicates tighter cost control and improved cash conversion. Sustained FCF supports reinvestment in products/services and funds working capital, enhancing long-term self-funded growth potential and financial stability.
Negative Factors
Modest and Uneven Revenue Growth
Flat to modest revenue growth limits operating leverage and the company’s ability to scale fixed-cost absorption. Over a multi-month horizon, weak top-line momentum constrains margin expansion potential and makes profitability improvements more dependent on one-off cost actions rather than sustainable demand growth.
Historical Cash-flow Volatility
Prior periods of negative FCF point to working-capital swings or investment timing that can stress operations when revenues weaken. This volatility reduces predictability of internally generated funds for investments or dividends and raises the need for conservative liquidity planning over the medium term.
Earnings and ROE Sensitivity
Material year-to-year swings in returns on equity indicate operating leverage or demand sensitivity. Such volatility complicates forecasting and heightens execution risk for sustaining returns, limiting investor visibility into recurring profitability over the coming months unless revenue consistency improves.

Ascom Holding AG (ASCN) vs. iShares MSCI Switzerland ETF (EWL)

Ascom Holding AG Business Overview & Revenue Model

Company DescriptionAscom Holding AG, together with its subsidiaries, provides healthcare ICT and mobile workflow solutions worldwide. The company offers nurse call and monitoring systems, including teleCARE IP that provides nurse call, alerts, messaging, monitoring, and wander management solution; and Telligence, a patient response system. It also provides Digistat software, suite of clinical workflows; Unite software, a workflow orchestration platform that integrates data and events from source systems, as well as alerts, chats, and tasks to enable users on various endpoint platforms. In addition, the company provides mobile devices, DECT and VoWiFi handsets, pagers, and IP-DECT solutions. Further, it offers consulting, implementation, training, support, and maintenance services. The company offers its solutions for hospitals acute care facilities; enterprises, including retail, security, and hospitality industries; and long-term care facilities. The company is headquartered in Baar, Switzerland.
How the Company Makes MoneyAscom makes money by selling and supporting mission-critical communication and workflow solutions, primarily to healthcare providers. Its revenue model is typically a mix of: (1) Solution and product sales: income from supplying software and integrated communication/workflow platforms (e.g., messaging, alarm/event management, workflow orchestration) and associated devices or infrastructure components used by clinical staff and care facilities. (2) Services revenue: fees for professional services such as system design, installation, integration with existing hospital systems, configuration, project management, and training. (3) Recurring support and lifecycle revenue: ongoing earnings from maintenance and support agreements, updates, and system lifecycle services that keep deployments operational over time; where applicable, software may be sold with recurring licensing/subscription elements rather than only one-time licenses (specific licensing mix not publicly confirmed here). (4) Channel/partner-enabled deployments: in many projects, Ascom solutions are implemented alongside or integrated with third-party hospital IT systems and clinical applications; revenue is supported by interoperability and integration work, and by sales executed directly and/or through regional sales organizations and partners (specific partners and commercial terms: null). Key factors contributing to earnings include long-term customer relationships in healthcare, the mission-critical nature of uptime and support, integration complexity that can drive services and support demand, and an installed base that generates follow-on revenue through upgrades, expansions, and maintenance.

Ascom Holding AG Financial Statement Overview

Summary
Profitability rebounded in 2025 (net income 15.1m; net margin ~5.2% vs ~1.3% in 2024) and the balance sheet is conservative with no reported debt in 2023–2025. Free cash flow improved in 2025 (31.6m), but revenue growth has been modest/uneven and cash flow was volatile historically (negative FCF in 2021–2022).
Income Statement
71
Positive
Profitability improved materially in 2025 versus 2024, with net income rebounding to 15.1m and margins recovering (net margin ~5.2% vs ~1.3% in 2024). Gross margin has been relatively steady in the mid-to-high 40% range, supporting earnings resilience. However, growth has been modest and uneven: 2025 revenue rose ~2.6% after a decline in 2024, and revenue has been broadly flat over the 2021–2025 period, which limits operating leverage and makes results more sensitive to execution.
Balance Sheet
86
Very Positive
The balance sheet looks conservative with no reported debt in 2023–2025 (and low debt even in earlier years), which reduces financial risk and interest burden. Equity has been stable (roughly 74.4m–80.0m) and returns on equity are strong in the better years (about ~18.9% in 2025 and ~22.1% in 2023), indicating good capital efficiency when profitability normalizes. The main watch-out is that returns can swing meaningfully with earnings (e.g., weaker 2024), suggesting the business has some operating volatility despite low leverage.
Cash Flow
67
Positive
Cash generation strengthened in 2025 with operating cash flow of 32.6m and free cash flow of 31.6m, and free cash flow up ~14.9% year over year. Cash conversion is generally reasonable, with free cash flow close to net income in 2025 (~0.97x). That said, cash flow has been less consistent historically (negative free cash flow in 2021–2022), and operating cash flow relative to revenue remains modest (mid-teens in 2023/2025 and lower in weaker years), indicating periodic working-capital or investment swings.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue292.10M286.70M297.30M297.40M291.50M
Gross Profit140.70M133.30M141.40M135.40M135.60M
EBITDA34.20M13.80M31.30M25.90M28.80M
Net Income15.10M3.70M17.40M11.00M13.50M
Balance Sheet
Total Assets199.60M189.90M197.20M201.80M194.70M
Cash, Cash Equivalents and Short-Term Investments29.60M18.60M24.70M26.60M29.50M
Total Debt0.000.000.0010.00M0.00
Total Liabilities119.70M115.50M118.50M128.40M114.70M
Stockholders Equity79.90M74.40M78.70M73.40M80.00M
Cash Flow
Free Cash Flow31.60M15.60M16.30M-3.20M-100.00K
Operating Cash Flow32.60M20.00M32.50M10.20M11.60M
Investing Cash Flow-10.80M-15.50M-16.20M-14.00M5.20M
Financing Cash Flow-10.40M-10.80M-17.20M2.20M-19.00M

Ascom Holding AG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
CHF181.76M8.954.02%2.75%
56
Neutral
CHF350.73M71.614.54%-2.42%-222.68%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
CHF1.13B-168.337.29%-112.70%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CH:ASCN
Ascom Holding AG
5.05
1.60
46.25%
MEDGF
Medacta Group SA
188.61
45.07
31.40%
SGFEF
Siegfried Holding AG
100.00
-2.66
-2.59%
DE:283
IVF HARTMANN Holding AG
150.00
20.66
15.98%
CH:MEDX
medmix AG
8.50
-1.75
-17.07%
CH:MED
Medartis Holding AG
83.00
7.10
9.35%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 12, 2026